Acute tumor lysis syndrome in a 7-month-old with hepatoblastoma

Current Opinion in Pediatrics

Volumn 22, Issue 1, 2010, Pages 113-116

  Bercovitz, Rachel S ^a   Greffe, Brian S ^a   Hunger, Stephen P ^a  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

Author keywords

Acute tumor lysis syndrome; Hepatoblastoma; Pediatrics

Indexed keywords

ALLOPURINOL; CISPLATIN; FLUOROURACIL; RASBURICASE; VINCRISTINE;

ACUTE LEUKEMIA; ALKALINIZATION; ARTICLE; CASE REPORT; CELL DEATH; DEATH; HEART ARRHYTHMIA; HEPATOBLASTOMA; HUMAN; HYDRATION; HYPERKALEMIA; HYPERPHOSPHATEMIA; HYPERURICEMIA; INFANT; KIDNEY FAILURE; LYMPHOMA; MALE; PRIORITY JOURNAL; TUMOR CELL; TUMOR CELL DESTRUCTION; TUMOR LYSIS SYNDROME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DISSEMINATED INTRAVASCULAR COAGULATION; FLUOROURACIL; HEMORRHAGE; HEPATOBLASTOMA; HUMANS; HYPERKALEMIA; HYPERURICEMIA; INFANT; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; NECROSIS; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; TUMOR LYSIS SYNDROME; VINCRISTINE;

EID: 75749121124     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32833499e5     Document Type: Article

References (20)

1. Tosi P, Barosi G, Lazzaro C, et al. Consensus conference on the management of tumor lysis syndrome. Haematologica 2008; 93:1877-1885.
2. Malogolowkin MH, Katzenstein H, Krailo MD, et al. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. J Clin Oncol 2006; 24:2879-2884.
3. Coiffier B, Altman A, Pui CH, et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 2008; 26:2767-2778.
4. Hochberg J, Cairo MS. Tumor lysis syndrome: current perspective. Haematologica 2008; 93:9-13.
5. Locatelli F, Rossi F. Incidence and pathogenesis of tumor lysis syndrome. Contrib Nephrol 2005; 147:61-68.
6. Baeksgaard L, Sorensen JB. Acute tumor lysis syndrome in solid tumors: a case report and review of the literature. Cancer Chemother Pharmacol 2003; 51:187-192.
7. Mott FE, Esana A, Chalmakjian C, Herrington J. Tumor lysis syndrome in solid tumors. Suportive Cancer Therapy 2005; 2:188-191.
8. Gemici C. Tumour lysis syndrome in solid tumours. Clin Oncol 2006; 18:773-780.
9. Trobaugh-Lotrario AD, Liang X, Janik JS, et al. Thymoma and tumor lysis syndrome in an adolescent. J Clin Oncol 2004; 22:995-997.
10. Sinha R, Bose S, Subramaniam R. Tumor lysis under anesthesia in a child. Acta Anaesthesiologica Scandinavica 2009; 53:131-133.
11. Lobe TE, Karkera MS, Custer MD, et al. Fatal refractory hyperkalemia due to tumor lysis during primary resection for hepatoblastoma. J Pediatr Surg 1990; 25:249-250.
12. Vaisban E, Braester A, Mosenzon O, et al. Spontaneous tumor lysis syndrome in solid tumors: really a rare condition? Am J Med Sci 2003; 1:38-40.
13. Wössmann W, Schrappe M, Meyer U, et al. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase. Ann Hematol 2003; 82:160-165.
14. Goldman SC, Holcenberg JS, Finklestein JZ, et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 2001; 97:2998-3003.
15. Ueng S. Rasburicase (Elitek): a novel agent for tumor lysis syndrome. Proc (Bayl Univ Med Cent) 2005; 18:275-279.
16. Liu CY, Sims-McCallum RP, Schiffer CA. A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy. Leukemia Research 2005; 29:463-465.
17. Hutcherson DR, Gammond DC, Bhatt MS, Faneuf M. Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy. Pharmacotherapy 2006; 26:242-247.
18. Hummel M, Reiter S, Adam K, et al. Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase. Eur J Hematol 2008; 80:331-336.
19. Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 2004; 127:3-11.
20. Evans KJ, Greenburg A. Hyperkalemia: a review. J Intensive Care Med 2005; 20:272-290.